Neuromodulation Beyond Itch is Blocked by Targeting IL‐13Rα1 with Eblasakimab 17 May, 2023 | Comments Off on Neuromodulation Beyond Itch is Blocked by Targeting IL‐13Rα1 with Eblasakimab Read More Categorized Eblasakimab, Translational work
Downstream effects of IL-13Rα1 blockade on Type 2 inflammation and Th1 immune axis activation in atopic dermatitis 17 May, 2023 | Comments Off on Downstream effects of IL-13Rα1 blockade on Type 2 inflammation and Th1 immune axis activation in atopic dermatitis Read More Categorized Eblasakimab, Translational work
Spatial localization and functional role of IL-13Rα1 signalling in atopic dermatitis 18 April, 2023 | Comments Off on Spatial localization and functional role of IL-13Rα1 signalling in atopic dermatitis Read More Categorized Eblasakimab, Translational work
Insight into novel itch pathways and spontaneous neuronal activity by targeting interleukin 13 receptor alpha 1 (IL13Rα1) with eblasakimab 18 April, 2023 | Comments Off on Insight into novel itch pathways and spontaneous neuronal activity by targeting interleukin 13 receptor alpha 1 (IL13Rα1) with eblasakimab Read More Categorized Eblasakimab, Translational work
New insights into neuronal itch mechanisms by targeting IL-13Rα1 with eblasakimab 18 April, 2023 | Comments Off on New insights into neuronal itch mechanisms by targeting IL-13Rα1 with eblasakimab Read More Categorized Eblasakimab, Translational work
Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models 22 February, 2021 | Comments Off on Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models Read More Categorized Farudodstat, Translational work
